We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Firms Oppose Grassley's Proposed Reimbursement Hikes
Sen. Chuck Grassley (R-Iowa) opposes a House proposal to base most spending cuts from federal healthcare programs on patient co-payment increases, and said he will fight to keep controversial Medicaid reimbursement rate hikes in the final reconciliation bill – increases that generic drugmakers say could drive some of them to drop out of Medicaid.